Pascal Millet
Overview
Explore the profile of Pascal Millet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
656
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Nzayirambaho M, de Dieu Bizimana J, Freund R, Millet P, Merrien F, Potel G, et al.
Pan Afr Med J
. 2013 Apr;
14:50.
PMID: 23560133
Introduction: This study aimed to evaluate the impact of home-based management of malaria (HBM) strategy on time to treatment and reported presumed malaria morbidity in children aged less than 5...
22.
Kauss T, Gaubert A, Boyer C, Ba B, Manse M, Massip S, et al.
Int J Pharm
. 2012 Dec;
441(1-2):218-26.
PMID: 23220079
Pharmaceutical development and manufacturing process optimization work was undertaken in order to propose a potential paediatric rectal formulation of azithromycin as an alternative to existing oral or injectable formulations. The...
23.
Kauss T, Gaudin K, Gaubert A, Ba B, Tagliaferri S, Fawaz F, et al.
Int J Pharm
. 2012 Aug;
436(1-2):624-30.
PMID: 22868232
The aim of this study was to identify a candidate formulation for further development of a home or near-home administrable paediatric rectal form of a broad-spectrum antibiotic - specially intended...
24.
Boyer C, Gaudin K, Kauss T, Gaubert A, Boudis A, Verschelden J, et al.
J Pharm Biomed Anal
. 2012 May;
67-68:10-5.
PMID: 22579599
Near infrared spectroscopy (NIRS) methods were developed for the determination of analytical content of an antimalarial-antibiotic (artesunate and azithromycin) co-formulation in hard gelatin capsule (HGC). The NIRS consists of pre-processing...
25.
Ratsimbasoa A, Ravony H, Vonimpaisomihanta J, Raherinjafy R, Jahevitra M, Rapelanoro R, et al.
Malar J
. 2012 Mar;
11:85.
PMID: 22443344
Background: Early diagnosis, as well as prompt and effective treatment of uncomplicated malaria, are essential components of the anti-malaria strategy in Madagascar to prevent severe malaria, reduce mortality and limit...
26.
Ratsimbasoa A, Ravony H, Vonimpaisomihanta J, Raherinjafy R, Jahevitra M, Rapelanoro R, et al.
Am J Trop Med Hyg
. 2012 Feb;
86(2):203-10.
PMID: 22302849
Home management of malaria is recommended for prompt, effective antimalarial treatment in children less than five years of age. Compliance, safety, and effectiveness of the new fixed-dose artesunate-amodiaquine regimen used...
27.
Lacaze C, Kauss T, Kiechel J, Caminiti A, Fawaz F, Terrassin L, et al.
Malar J
. 2011 May;
10:142.
PMID: 21605361
Background: Artemisinin-based combination therapy is currently recommended worldwide for the treatment of uncomplicated malaria. Fixed-dose combinations are preferred as they favour compliance. This paper reports on the initial phases of...
28.
Vareil M, Tandonnet O, Chemoul A, Bogreau H, Saint-Leger M, Micheau M, et al.
Emerg Infect Dis
. 2011 Feb;
17(2):248-50.
PMID: 21291597
Plasmodium falciparum malaria is usually transmitted by mosquitoes. We report 2 cases in France transmitted by other modes: occupational blood exposure and blood transfusion. Even where malaria is not endemic,...
29.
Manirakiza A, Njuimo S, Le Faou A, Malvy D, Millet P
East Afr J Public Health
. 2010 Sep;
6(3):292-5.
PMID: 20803921
National malaria management policy is based upon the availability of effective and affordable antimalarial drugs. This study was undertaken to evaluate the quality of the treatment of uncomplicated malaria cases...
30.
Kauss T, Fawaz F, Guyot M, Lagueny A, Dos Santos I, Bonini F, et al.
Int J Pharm
. 2010 Aug;
PMID: 20685236
Artemisinin-based combination therapies, including artesunate (AS)+amodiaquine (AQ), are the currently recommended first-line treatment of uncomplicated falciparum malaria. Fixed-dose co-formulations offer logistic and adherence advantages. This paper reports the initial research...